COMMUNIQUÉS West-GlobeNewswire

Jushi Holdings Inc. Announces Amendment to CEO Employment Agreement
16/12/2025
BOCA RATON, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“ Jushi ” or the “ Company ”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, announces that in order to [...]
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
16/12/2025
LANGHORNE, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high- [...]
Annovis to Host Corporate Update Webinar on January 28, 2026
16/12/2025
MALVERN, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases [...]
Elicio Therapeutics Reports Inducement Grants
16/12/2025
BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
16/12/2025
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that it is [...]
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
16/12/2025
The registrational TACTI-004 Phase III has enrolled 289 patients globally, over 38% of the trial’s targeted enrolment Strong operational progress continues globally with over 120 activated clinical sites and 27 [...]
Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America
16/12/2025
Role Supports Synergy’s Expanding Presence in Mexico, Including Initial Product Shipments to Costco Mexico WESTBROOK, Maine, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company [...]
Marine Biologics Named a Top Food Technology Company for 2025 in Global Food Tech Awards
16/12/2025
Innovator building the AI for clean-label ingredient discovery is recognized as a global game-changing technology shaping the future of food BERKELEY, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Marine Biologics today [...]
Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide
16/12/2025
TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the University Health Network Research Ethics Board (“UHN REB”) has [...]
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
16/12/2025
Strong preclinical data support planned clinical trial initiation in 2026 Oslo, Norway, 16 December 2025– Zelluna (OSE: ZLNA), a company developing off-the-shelf cell therapies for cancer, today announced the [...]
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
16/12/2025
BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leader in AI-driven neurophysiology and precision drug development, today announced a collaboration with Harmony Biosciences (Nasdaq: HRMY), a [...]
Culture Biosciences Announces Close of Series C Round to Accelerate Commercial Growth of Stratyx 250 and Console Platform
16/12/2025
New funding accelerates the expansion of the Stratyx™ platform, advancing automated, cloud-connected bioprocessing and AI-driven software capabilities SOUTH SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 16, 2025 (GLOBE [...]
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm
16/12/2025
Acquisition provides Virbac with a leading specialty product, in a growing segment, to improve the quality of life for senior cats. We are delighted to announce the acquisition of an innovative drug from Norbrook to [...]
VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm
16/12/2025
Cette acquisition apporte à Virbac un produit de spécialité de premier plan, sur un segment en croissance, pour améliorer la qualité de vie des chats âgés. Nous sommes ravis d'annoncer l'acquisition auprès de Norbrook d [...]
Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026
16/12/2025
Press Release Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026 All clinical trial and long-term stability data required for the preparation of the New Drug [...]
Nicox finalise la génération des données clés de demande d’autorisation de mise sur le marché de NCX 470 pour un dépôt maintenu au premier semestre 2026
16/12/2025
Communiqué de presse Nicox finalise la génération des données clés de demande d’autorisation de mise sur le marché de NCX 470 pour un dépôt maintenu au premier semestre 2026 Toutes les données d’ essais cliniques et de [...]
Acentra Health Named to Northern Virginia Technology Council’s Tech100
16/12/2025
Award honors Northern Virginia organizations for making a positive impact on the region’s technology community MCLEAN, Va., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company [...]
Brain Based Health Solutions’ Dr. Clint Steele Releases “101 Brain Hacks” to Rewrite the Future of Dementia Prevention and Even Reversal
16/12/2025
Portland, Maine, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Most people believe dementia is a life sentence. Dr. Clint Steele once believed that, too, until a moment in his practice changed everything. Today, the #1 best-selling [...]
Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones
15/12/2025
Holders will have until December 30, 2025 to exercise Tranche A Warrants at $1.05 per share, enabling up to $17.9 million in potential gross proceeds BURLINGTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, [...]

Pages